These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 526002

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution.
    Swenson JM, Thornsberry C, Silcox VA.
    Antimicrob Agents Chemother; 1982 Aug; 22(2):186-92. PubMed ID: 6927280
    [Abstract] [Full Text] [Related]

  • 5. Disk diffusion testing with polymyxin and amikacin for differentiation of Mycobacterium fortuitum and Mycobacterium chelonei.
    Wallace RJ, Swenson JM, Silcox VA, Good RC.
    J Clin Microbiol; 1982 Dec; 16(6):1003-6. PubMed ID: 6298271
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Sulfonamide activity against Mycobacterium fortuitum and Mycobacterium chelonei.
    Wallace RJ, Jones DB, Wiss K.
    Rev Infect Dis; 1981 Dec; 3(5):898-904. PubMed ID: 7339821
    [Abstract] [Full Text] [Related]

  • 8. In vitro antimicrobial susceptibility testing of rapidly growing mycobacteria using the tablet diffusion method: resistance pattern of Norwegian Mycobacterium fortuitum and Mycobacterium chelonae isolates.
    Hoel T, Casals JB, Eng J.
    APMIS; 1993 Jan; 101(1):27-32. PubMed ID: 8457323
    [Abstract] [Full Text] [Related]

  • 9. Mutational resistance as the mechanism of acquired drug resistance to aminoglycosides and antibacterial agents in Mycobacterium fortuitum and Mycobacterium chelonei. Evidence is based on plasmid analysis, mutational frequencies, and aminoglycoside-modifying enzyme assays.
    Wallace RJ, Hull SI, Bobey DG, Price KE, Swenson JM, Steele LC, Christensen L.
    Am Rev Respir Dis; 1985 Aug; 132(2):409-16. PubMed ID: 4026065
    [Abstract] [Full Text] [Related]

  • 10. In vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to cefmetazole.
    Casal MJ, Rodriguez FC, Benavente MC.
    Antimicrob Agents Chemother; 1985 Feb; 27(2):282-3. PubMed ID: 3857020
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vitro susceptiiblity of Mycobacterium fortuitum and Mycobacterium chelonei to amikacin.
    Dalovisio JR, Pankey GA.
    J Infect Dis; 1978 Mar; 137(3):318-21. PubMed ID: 632627
    [Abstract] [Full Text] [Related]

  • 13. [Study of "in vitro" susceptibility of "Mycobacterium fortuitum" to aminoglycoside and beta-lactam antibiotics (author's transl)].
    Casal M, Rodriguez F.
    Ann Microbiol (Paris); 1981 Mar; 132B(1):51-6. PubMed ID: 7305191
    [Abstract] [Full Text] [Related]

  • 14. In vitro susceptibility of Mycobacterium marinum to eight antimicrobial agents.
    Sanders WJ, Wolinsky E.
    Antimicrob Agents Chemother; 1980 Oct; 18(4):529-31. PubMed ID: 7447416
    [Abstract] [Full Text] [Related]

  • 15. A comparison between disk diffusion and microdilution for susceptibility testing of Mycobacterium fortuitum complex.
    Esteban J, Gadea I, Torres MV, Cabria F, Rollan E, Santos-O'Connor FG, Fernández-Roblas R, Soriano F.
    J Chemother; 2002 Dec; 14(6):547-53. PubMed ID: 12583544
    [Abstract] [Full Text] [Related]

  • 16. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.
    Wallace RJ, Swenson JM, Silcox VA, Bullen MG.
    J Infect Dis; 1985 Sep; 152(3):500-14. PubMed ID: 3875667
    [Abstract] [Full Text] [Related]

  • 17. Susceptibility of Mycobacterium marinum to tetracyclines and aminoglycosides.
    Wallace RJ, Wiss K.
    Antimicrob Agents Chemother; 1981 Nov; 20(5):610-2. PubMed ID: 7325629
    [Abstract] [Full Text] [Related]

  • 18. In vitro susceptibilities of rapidly growing mycobacteria to newer antimicrobial agents.
    Khardori N, Nguyen H, Rosenbaum B, Rolston K, Bodey GP.
    Antimicrob Agents Chemother; 1994 Jan; 38(1):134-7. PubMed ID: 8141567
    [Abstract] [Full Text] [Related]

  • 19. Antimicrobial activity of ofloxacin and other agents against mycobacterial isolates from postoperative sternotomy wounds.
    Yew WW, Kwan SY, Ma WK, Lui KS, Aung MK.
    Clin Ther; 1989 Jan; 11(6):775-85. PubMed ID: 2611821
    [Abstract] [Full Text] [Related]

  • 20. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
    Heidarieh P, Mirsaeidi M, Hashemzadeh M, Feizabadi MM, Bostanabad SZ, Nobar MG, Hashemi Shahraki A.
    Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.